Ocrelizumab
Information about Ocrelizumab
Ocrelizumab Uses
Ocrelizumab is used in the treatment of multiple sclerosis (MS) and psoriasis.
How Ocrelizumab works
Ocrelizumab works by targeting a specific protein called CD20, found on the surface of certain B lymphocytes, which are immune cells involved in the damage caused by multiple sclerosis (MS). By binding to CD20, Ocrelizumab eliminates these harmful B cells, reducing the immune attack on the nervous system. This helps control the disease, protect the neurological system, and slow the progression of MS, improving overall outcomes for patients.
Common side effects of Ocrelizumab
Respiratory tract infection, Infusion reaction, Skin infection
Available Medicine for Ocrelizumab
OcrevusRoche Diagnostics India Pvt. Ltd.
₹3075001 variant(s)
Expert advice for Ocrelizumab
- Always undergo hepatitis B screening before starting treatment. If you have had the virus, your doctor will monitor you closely during and after treatment.
- Patients need to finish all necessary vaccinations at least six weeks before starting Ocrelizumab.
- It is not advised to provide live or live-attenuated vaccines when treating Ocrelizumab or until B-cell recovery.
- Be vigilant about signs of infection, such as fever, chills, or persistent cough, and report them to your doctor immediately. Delay treatment if you have an active infection.